QNET earned three Stevie Awards at the 22nd Annual International Business Awards in October 2025, including a Gold award for its QNET Against Scams campaign. The recognition caps a busy year for the ...

Bitcoin BTC $89,672.58 has room to run — and fast — according to a new forecast from JPMorgan analysts who see the cryptocurrency reaching as high as $170,000 within the next six to 12 months. In a ...

Vanguard has broadened its suite of model portfolios for financial advisors with the introduction of two new fixed income offerings. The Risk Diversification Tax-Aware Model and the Income Focused ...

Washington — President Trump on Wednesday showed off a model of what may be his next Washington, D.C., development project, an arch that resembles the Arc de Triomphe in Paris and is being referred to ...

Improving compliance among taxpayers is a major concern for governments around the world. Tax administrations globally are at a pivotal moment, as modern technology reshapes the tax ecosystem and ...

In September 2010, Halo changed forever. Halo: Reach, a prequel to Bungie’s Halo trilogy and the last game developed by the studio while under Microsoft’s umbrella, messed with established canon and ...

Reach is the debut title from nDreams Elevation, coming to all major VR headsets next month. I got a chance to go hands-on with the Quest 3 version during the first in-person VR Games Showcase event ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Tesla is launching a longer version of the Model Y in China. But will this new model reach the United States? Amy Coney Barrett responds to concern Supreme Court protecting Donald Trump Emma Heming ...

Google’s Gemini model landing on Oracle Cloud marks a shift for enterprise AI adoption, bringing high-profile artificial intelligence out of Google’s exclusive orbit and into broader business ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.